Applied Immune Technologies

Applied Immune Technologies Ltd. is dedicated to developing therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-cell receptor-like (TCRL) antibodies targeting intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; vaccine design, validation, and monitoring; as well as analysis of antigen presentation in diseases.